Publications
Consensus meeting summary
The online consensus meeting for the ‘how to measure’ stage of the PC-COS study was held on September 29, 2022. The process aimed to reach consensus, where possible, regarding recommended outcome measurement instruments for the core outcome domains identified in the preceding ‘what to measure’ stage of the PC-COS study.
Protocol
The amendment to original PC-COS 'HOW' Protocol: changes to protocol, dates of change, reasons for changes, etc.
Protocol
Now that we have defined a COS for Post COVID-19 condition on the outcome domain level (i.e. WHAT to measure), it is important to achieve consensus on HOW these domains should be
measured, i.e., which outcome measurement instruments should be selected. When using the term ‘instrument,’ we are referring to any outcome measurement instruments, tools, procedures, etc., that are used to measure an outcome domain...
measured, i.e., which outcome measurement instruments should be selected. When using the term ‘instrument,’ we are referring to any outcome measurement instruments, tools, procedures, etc., that are used to measure an outcome domain...
Position Paper
Recent data suggest that many people experience Post COVID-19 Condition (Long COVID) following the acute phase of the SaRS CoV-2 infection. At present there is no agreement on what patient health outcomes should be measured in Post COVID-19 Condition. We aimed to identify core outcomes for Post COVID-19 Condition that stakeholders considered critical to assess in all research studies and clinical practice.
Podcast
Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.
The Lancet Respiratory Medicine Podcast Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
The Lancet Respiratory Medicine Podcast Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Opinion
A substantial portion of people with COVID-19 subsequently experience lasting symptoms including fatigue, shortness of breath, and neurological complaints such as cognitive dysfunction many months after acute infection. Emerging evidence suggests that this condition, commonly referred to as long COVID but also known as post-acute sequelae of SARS-CoV-2 infection (PASC) or post-COVID-19 condition, could become a significant global health burden.
PC-COS Children Comment
Although the prevalence of post-COVID-19 condition in children and young people might be lower than in adult populations, the impact on physical and psychological health could be lifelong, not only creating increased demands on health services but also having wider socioeconomic implications for the affected children and society—eg, by adversely affecting career opportunities and earnings, productivity, and economics, as well as social activities, relationships, and longevity. There is an urgent need to initiate projects that aim to develop a COS and associated measurements.
COMET
Core Outcome Measures for Post-Covid condition/Long Covid study registration in Core Outcome Measures in Effectiveness Trials (COMET) database
